Doha, October 12, 2026 : Hamad Medical Corporation (HMC) has launched a new specialized clinic at the National Center for Cancer Care and Research (NCCCR) for cancer patients who need repeated intravenous treatments. The clinic provides specialized assessment to determine the most suitable method of care for each patient’s condition and treatment plan.
The clinic brings together oncology and vascular surgery teams from the NCCCR and the Vascular Surgery Department at Hamad General Hospital (HGH). This gives a full picture of each patient’s intravenous treatment needs and supports planning and follow-up at every stage of care.
The clinic assesses each case, determines the most appropriate option, and monitors the patient’s health needs and the type of treatment they receive. This helps medical teams plan ahead and avoid unnecessary delays or difficulties during treatment.
Dr. Mohammed Salem Al Hassan, Medical Director and CEO of the NCCCR and Chairman of Cancer Services at HMC, said the clinic is part of ongoing efforts to develop cancer care services that meet patients’ diverse needs throughout their treatment journey. He said it provides specialized care for a critical challenge many patients face during treatment.
Dr. Al Hassan added that caring for cancer patients requires ongoing integration among medical specialties and areas of expertise, and that HMC places great importance on that integration to ensure continuity and coordination of care.
Dr. Al Harith Al Khater, Head of Oncology, Palliative Care and Urgent Care Services at the NCCCR, said some cancer patients need intravenous treatment over extended periods and their needs may change as treatment continues. He said the clinic allows medical teams to assess those needs early and address them as part of the treatment plan, helping ease the treatment journey and manage challenges that arise.
Dr. Hassan Ali Saud Al-Thani, Head of the Trauma, Vascular, and General Surgery Department at HGH, said some patients struggle to maintain suitable venous access, particularly when intravenous treatments are repeated. He said specialized assessment helps determine the right options for each case based on the patient’s needs and the nature of their treatment.
One patient described the experience: “I used to feel anxious before my chemotherapy sessions because of the difficulty accessing my vein. Sometimes this meant having to make repeated attempts to insert the needle, which caused me pain and discomfort. After I was referred to the clinic, the team, along with the Vascular Surgery team, listened to my concerns and explained the option that was appropriate for my condition. They answered my questions clearly, which made me feel more reassured. After the appropriate catheter was inserted for my treatment, receiving my medications became easier and more comfortable.”
Source: QNA
